[Development of morbidity in hemolytic disease of the newborn after the introduction of immune prophylaxis at the Rostock blood exchange center from 1970 to 1980].
The development of morbus haemolyticus neonatorum morbidity is demonstrated by referring to the example of the "exchange centre" in Rostock after using anti-D-immunprophylaxis for more than 10 years. The level achieved is compared with findings in international studies. The main cause for rest morbidity consists in omitting indicated immunoprophylaxis. Further progress in reducing the morbidity of morbus haemolyticus neonatorum can only be achieved by keeping physicians informed about the deleterious consequences of anti-D-immunisation having occurred.
D004899:Erythroblastosis, Fetal / Q000453:epidemiology* / Q000517:prevention & control; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005859:Germany, East; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000008:administration & dosage; D007231:Infant, Newborn; D011247:Pregnancy
D007074:Immunoglobulin G
Die Entwicklung der Morbidität des Morbus haemolyticus neonatorum nach Einführung der Immunprophylaxe im Blutaustauschzentrum Rostock von 1970 bis 1980.